Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project.


Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 07 04 2023
accepted: 24 04 2023
medline: 31 7 2023
pubmed: 5 5 2023
entrez: 5 5 2023
Statut: ppublish

Résumé

Guidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain knowledge on SC procedures in Oncology Centers (OCs) for advanced cancer patients and a first impression on the consequences of SC. The KeSBa project consisted of three phases: pilot, 3 months screening and feedback phase. Participating OCs decided to use either the Minimal Documentation System (MIDOS) or the Integrated Palliative care Outcome Scale (IPOS) and defined the cutoff values for positive screening results. Out of 172 certified German OCs, 40 (23%) participated in the KeSBa pilot phase, 29 (16.8%) in the 3 months screening phase using MIDOS (n = 18, 58.6%) or IPOS (n = 11, 41.3%) and in the feedback round. 25/29 performed paper-based screening (86.2%). 2.963 CPs were screened. Results were documented for 1255 (42.2%, SC +) positive and 874 (29.5%, SC-) negative screenings depending on the center´s schedules: 452 SC + CPs (28.4%) and 42 SC- CPs (2.6%) had contact to specialized palliative care or other supportive specialist teams afterwards, 458 SC + CPs (28.8%) and 605 SC- CPs (38.1%) remained in standard oncology care. In the feedback round missing resources (personal and IT) and improved communication were mentioned most often. Routine SC is feasible in advanced CPs treated in OCs but associated with considerable workload. In 42.2% of CPs SC was classified as positive, indicating the need of further diagnostics or professional judgment. SC requires staff and IT resources.

Identifiants

pubmed: 37145199
doi: 10.1007/s00432-023-04818-8
pii: 10.1007/s00432-023-04818-8
pmc: PMC10374724
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8829-8842

Informations de copyright

© 2023. The Author(s).

Références

JAMA Oncol. 2017 Aug 01;3(8):1043-1050
pubmed: 28208174
JAMA. 2022 Jun 28;327(24):2413-2422
pubmed: 35661856
Z Psychosom Med Psychother. 2020 Jun;66(2):133-148
pubmed: 32552586
J Pain Symptom Manage. 2012 Sep;44(3):340-50
pubmed: 22699092
Palliat Med. 2016 Jun;30(6):599-610
pubmed: 26415736
J Pain Symptom Manage. 2010 Feb;39(2):241-9
pubmed: 19963335
Schmerz. 2010 Dec;24(6):596-604
pubmed: 20882300
Ann Oncol. 2016 Dec;27(12):2294-2299
pubmed: 27681863
Support Care Cancer. 2019 Jan;27(1):209-218
pubmed: 29931490
J Pain Symptom Manage. 2016 Feb;51(2):262-9
pubmed: 26482223
Support Care Cancer. 2016 Jul;24(7):3047-56
pubmed: 26887586
J Clin Oncol. 2023 Feb 1;41(4):835-846
pubmed: 36356279
Front Oncol. 2023 Jan 26;13:1002499
pubmed: 36776341
J Clin Oncol. 2004 Feb 15;22(4):714-24
pubmed: 14966096
Palliat Med. 2018 Jan;32(1):143-155
pubmed: 29154724
Lancet Oncol. 2018 Nov;19(11):e588-e653
pubmed: 30344075
Support Care Cancer. 2021 Dec;29(12):7715-7724
pubmed: 34159428
Psychooncology. 2011 Mar;20(3):287-93
pubmed: 20669340
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Ann Oncol. 2015 Sep;26(9):1953-1959
pubmed: 26088196
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
Lancet. 2014 May 17;383(9930):1721-30
pubmed: 24559581
JCO Oncol Pract. 2021 Oct;17(10):e1584-e1591
pubmed: 33571007
BMC Health Serv Res. 2019 Mar 12;19(1):157
pubmed: 30866912
J Palliat Care. 1991 Summer;7(2):6-9
pubmed: 1714502
Oncologist. 2021 Jun;26(6):e1058-e1065
pubmed: 33687742
Palliat Med. 2021 Apr;35(4):636-650
pubmed: 33706600
Cancer. 2010 Dec 15;116(24):5767-76
pubmed: 21136579
Palliat Med. 2019 Sep;33(8):1045-1057
pubmed: 31185804
Support Care Cancer. 2021 Feb;29(2):573-593
pubmed: 32875373
Qual Health Care. 1999 Dec;8(4):219-27
pubmed: 10847883
J Clin Oncol. 2020 Mar 20;38(9):987-994
pubmed: 32023165
Oncologist. 2017 Aug;22(8):995-1001
pubmed: 28476945
J Pain Symptom Manage. 2013 Nov;46(5):652-60
pubmed: 23566756
J Pain Symptom Manage. 2020 Oct;60(4):754-764
pubmed: 32387576
Oncologist. 2021 Oct;26(10):e1800-e1811
pubmed: 34216415

Auteurs

Friederike Braulke (F)

Comprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.

Servet Para (S)

Interdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.

Bernd Alt-Epping (B)

Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Mitra Tewes (M)

Department of Palliative Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Markus Bäumer (M)

Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany.

Birgit Haberland (B)

LMU Klinikum München, München, Germany.

Regine Mayer-Steinacker (R)

Comprehensive Cancer Center Ulm. Medical Center, Ulm University, Ulm, Germany.

Anne Hopprich (A)

Department of Radiooncology and Radiotherapy, University Medical Center Mainz, Mainz, Germany.

Maike de Wit (M)

Cancer Center Berlin-Neukölln - Vivantes Klinikum Neukölln, Berlin, Germany.

Michaela Grabe (M)

Cancer Center Rems-Murr-Hospital Winnenden, Winnenden, Germany.

Sophia Bender-Säbelkampf (S)

Universitätsklinikum Erlangen, Erlangen, Germany.

Caroline Weßling (C)

Clemenshospital Münster, Münster, Germany.

Christoph Aulmann (C)

Augsburg University Hospital, Augsburg, Germany.

Christina Gerlach (C)

Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Pascale Regincos (P)

Clinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.

Ferdinand Fischer (F)

Hospital Ludwigshafen am Rhein gGmbH, Ludwigshafen, Germany.

Soraya Haarmann (S)

Kliniken Heilbronn GmbH, Fachklinik Löwenstein, Löwenstein, Germany.

Tatjana Huys (T)

Universitätsklinikum Gießen, Giessen, Germany.

Sabine Drygas (S)

Brüderkrankenhaus St. Josef Paderborn, Paderborn, Germany.

Anett Rambau (A)

Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.

Alexander Kiani (A)

Klinikum Bayreuth GmbH, and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.

Astrid Schnabel (A)

Leipzig University Cancer Center, Leipzig, Germany.

Christoph Buhl (C)

Department of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.

Stefanie Seipke (S)

Comprehensive Cancer Center, Hannover Medical School, Hannover, Germany.

Sonja Hiemer (S)

Klinikum St. Georg Leipzig, Leipzig, Germany.

Silke Polata (S)

Evangelisches Waldkrankenhaus Berlin-Spandau, Berlin, Germany.

Maximilian Meßmann (M)

Department of Palliative Medicine, Hospital St. Elisabeth Straubing GmbH, Straubing, Germany.

Anna Hansmeier (A)

Mathias-Spital Rheine-Ibbenbüren, Rheine, Germany.

Louiza Anastasiadou (L)

Agaplesion Markus Krankenhaus Frankfurt, Frankfurt, Germany.

Anne Letsch (A)

Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

Daniel Wecht (D)

Specialist Care in Oncology and Palliative Care, University Hospital Gießen and Marburg, Marburg, Germany.

Matthias Hellberg-Naegele (M)

Advanced Practice Nurse, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

Utz Krug (U)

Department of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.

Ulrich Wedding (U)

Department of Palliative Care, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany. ulrich.wedding@med.uni-jena.de.

Birgitt van Oorschot (B)

Interdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH